Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine dose-ranging trial with propofol for painless gastrointestinal endoscopy
ChiCTR2500100399Phase 4Not yet recruiting
- Sponsor
- Lishui City Central Hospital
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine, propofol and sufentanil in None (4 arms), sponsored by Lishui City Central Hospital. Primary endpoints: Mean arterial pressure, Heart rate and 2 more. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
oliceridinepropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2500100399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100399.